Facebook tracking pixel
S10.AI
ICD-10-CM · A63.0GeneralSystemic

Anal Condyloma

Find comprehensive information on Anal Condyloma, also known as Anogenital Warts or Condyloma Acuminatum. This resource provides healthcare professionals with details on diagnosis, clinical documentation, and medical coding for Anal Condyloma. Learn about relevant ICD-10 codes, SNOMED CT concepts, and best practices for accurate medical record keeping related to Anogenital Warts. Improve your clinical documentation and coding accuracy for Condyloma Acuminatum with this essential guide for healthcare providers.

Also known as
Anogenital WartsCondyloma Acuminatum
Definition

Small, fleshy growths caused by HPV infection in the anal area.

Clinical signs

Itching, pain, bleeding, visible warts around the anus or genitals.

Common settings

STD clinics, dermatology offices, primary care facilities.

Related Codes

ICD-10 Code Families

Complete code families applicable to A63.0

A63.0
Anogenital (venereal) warts
A50-A64
Infections with a predominantly sexual mode of transmission
B07
Viral warts
Code Comparison

When to use each related code

DescriptionWhen to use
Genital warts caused by HPV.Visible genital warts. Confirm with biopsy if needed. Consider HPV typing.
Precancerous changes in anal or genital skin caused by HPV.Abnormal Pap smear, colposcopy, or biopsy showing AIN or VIN. Exclude invasive cancer.
Flat, often subclinical HPV infection in the genital area.Suspected HPV infection but no visible warts. May be diagnosed via specialized tests like acetic acid application or HPV DNA testing.
Documentation

Best-practice checklist

  • Document wart location, size, morphology.
  • Note patient HPV vaccination status.
  • Record any associated symptoms (e.g., itching, bleeding).
  • If biopsied, document pathology results.
  • Detail treatment plan (e.g., cryotherapy, surgery).
Coding & Audit Risks

Common pitfalls to avoid

Unspecified Site

Coding for 'Anal Condyloma' lacks anatomical specificity. Documentation must clarify location (perianal, anal canal, etc.) for accurate coding and reimbursement.

HPV Typing Omission

Missing HPV typing information can impact medical coding and research data accuracy. Clinical documentation should specify the HPV type if known.

Benign vs. Malignant

Distinguishing between benign condyloma and potentially malignant lesions is crucial. Accurate documentation and coding impact treatment and surveillance.

Mitigation

Best-practice tips

  • 01ICD-10 K61.1, A93.0, document HPV type for Anal Condyloma.
  • 02Condyloma Acuminatum: Complete anoscopy, biopsy for dysplasia.
  • 03Anogenital Warts: Patient education on safe sex practices.
  • 04HPV vaccination to prevent recurrence, document in chart.
  • 05Surgical removal, cryotherapy, topical tx, follow-up essential.
Clinical Decision Support

Step-by-step checklist

  1. 1

    Confirm anogenital warts via visual inspection or biopsy (ICD-10: A63.0)

  2. 2

    Document wart size, location, and morphology for accurate coding

  3. 3

    Rule out other STIs (e.g., syphilis, herpes) with appropriate testing

  4. 4

    Assess HIV risk and offer testing per guidelines

Documentation Template

Ready-to-paste narrative

Patient presents with complaints consistent with anal condyloma, also known as anogenital warts or condyloma acuminatum.  Physical examination reveals the presence of flesh-colored to pinkish, exophytic papules or plaques in the perianal region.  Lesions may be singular or multiple, and range in size from small, barely visible growths to larger, cauliflower-like clusters.  Patient reports symptoms including itching, discomfort, bleeding, and or pain in the anal area.  Differential diagnoses considered include hemorrhoids, skin tags, and squamous cell carcinoma.  Diagnosis of anal condyloma is confirmed by visual inspection and may be supplemented by anoscopy, high-resolution anoscopy, or biopsy if necessary.  HPV typing may be considered for risk stratification and epidemiological purposes.  Treatment options discussed with the patient include topical medications such as imiquimod or podofilox, provider-applied therapies such as trichloroacetic acid or cryotherapy, and surgical excision.  Patient education provided on the importance of safe sex practices, HPV vaccination for eligible individuals, and follow-up care to monitor treatment response and recurrence.  ICD-10 code A63.0 and relevant CPT codes for procedures performed will be documented for medical billing and coding purposes.  The patient was advised on the potential for recurrence and the importance of regular follow-up examinations.
FAQs

Common questions and answers

What are the most effective differential diagnosis strategies for distinguishing Anal Condyloma (Anogenital Warts/Condyloma Acuminatum) from other similar-appearing anogenital lesions in clinical practice?+

Differentiating Anal Condyloma from other anogenital lesions requires a thorough clinical examination combined with targeted diagnostic testing. While the characteristic appearance of Condyloma Acuminatum (cauliflower-like or papular lesions) can be suggestive, it's crucial to rule out other conditions like squamous cell carcinoma, condyloma lata (secondary syphilis), pearly penile papules, and molluscum contagiosum. High-resolution anoscopy and biopsy are often necessary for definitive diagnosis, particularly for atypical or pigmented lesions. Acetic acid application can enhance visualization of subclinical warts, but it is not diagnostic on its own. Serological testing for syphilis and HPV typing can provide further clarification. Consider implementing a standardized diagnostic protocol for all suspected cases of Anal Condyloma to ensure accurate diagnosis and appropriate management. Explore how advanced imaging techniques, such as high-resolution anoscopy, can improve diagnostic accuracy.

How do current clinical guidelines recommend managing Anal Condyloma in patients, including treatment options and patient education strategies for recurrence prevention?+

Current clinical guidelines for Anal Condyloma management emphasize patient-centered care, considering factors such as lesion size, location, and patient preference. Treatment options include topical agents (e.g., podophyllotoxin, imiquimod), ablative therapies (e.g., cryotherapy, electrocautery, laser surgery), and surgical excision. Patient education plays a crucial role in recurrence prevention. Discuss strategies for minimizing risk factors, including safe sex practices and HPV vaccination. It's important to explain that treatment clears the existing lesions but does not eradicate HPV, meaning recurrence is possible. Encourage open communication with patients about treatment expectations and potential side effects. Learn more about the latest evidence-based recommendations for Anal Condyloma management from reputable clinical guidelines.

What are the key considerations for clinicians regarding the association between Anal Condyloma (Anogenital Warts) and an increased risk of anal cancer, and how should this inform patient counseling and screening protocols?+

While Anal Condyloma itself is benign, persistent infection with high-risk HPV types associated with Anogenital Warts can increase the risk of anal cancer. Clinicians should counsel patients on this link, emphasizing the importance of regular screening, particularly for those with persistent or recurrent Condyloma. High-resolution anoscopy and anal cytology can be valuable screening tools. Discuss the role of HPV vaccination in preventing anal cancer, even for those who have already had Anal Condyloma. Clear communication about risk stratification and individualized screening protocols is essential for promoting patient engagement in preventive care. Explore how risk-based screening strategies can optimize anal cancer prevention efforts.

Clinical accuracy: This information is provided for documentation and coding guidance and should not replace professional medical judgment.

Coding standard: ICD-10-CM, current FY guidelines.